This renewal proposal seeks continuation of the Training in Developmental Cardiovascular Biology Program, initiated 21 years ago. Of the 11 fellows supported by this Program over the previous 10 years, and who have completed the program, 5 have academic appointments at outstanding institutions and 10 are actively engaged in federally- or privately-funded research programs. This Program will continue to utilize the outstanding physiology and molecular and cellular biology laboratories at the Cardiovascular Research Institute and several UCSF departments to train basic, clinical, and translational scientists who will be at the forefront of developmental cardiovascular research in the coming decades. Modern physiologic and molecular approaches have produced remarkable advances in our knowledge of cardiovascular biology and disease, and the fields of human genetics and stem cell biology are providing still more opportunities. These developments promise rapid scientific progress and underscore the ongoing need for well-trained investigators to both continue this work and build bridges between basic discovery and the advancement of human health. To this end we will: 1. Exploit the unique training opportunities in the CVRI, the Department of Pediatrics, and UCSF in general, in areas of basic biology, clinical epidemiology, and translational research. 2. Recruit graduates of top Ph.D. and M.D.-Ph.D. programs to careers in cardiovascular research. 3. Combine clinical pediatric cardiology training with a rigorous grounding in basic or clinical/translational research to facilitate the training of physician-scientists. This grant will support 6 postdoctoral fellows, each for 2 years, and features three Tracks. Track I trainees will be M.D.s seeking both clinical pediatric cardiology and basic science research training. Trainees in this Track will receive support from this training grant only for the research component of their training. Track II trainees will be Ph.D.s or M.D.-Ph.D.s who will compete openly for postdoctoral positions in basic cardiovascular biology. Track III trainees will be M.D.s seeking advanced training in clinical or translational research relevant to cardiovascular health and disease. A strong didactic curriculum will be provided in a rich scientific environment with rigorous graduate courses and regular trainee meetings. Each trainee will execute a research project with one of the 25 outstanding program faculty preceptors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007544-24
Application #
7433186
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Carlson, Drew E
Project Start
1983-07-01
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
24
Fiscal Year
2008
Total Cost
$261,118
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Anderson, Courtney M; Hu, Jianxin; Thomas, Reuben et al. (2017) Cooperative activation of cardiac transcription through myocardin bridging of paired MEF2 sites. Development 144:1235-1241
Hwa, Jennifer J; Beckouche, Nathan; Huang, Lawrence et al. (2017) Abnormal arterial-venous fusions and fate specification in mouse embryos lacking blood flow. Sci Rep 7:11965
Judge, Luke M; Perez-Bermejo, Juan A; Truong, Annie et al. (2017) A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress. JCI Insight 2:
Barnes, Ralston M; Harris, Ian S; Jaehnig, Eric J et al. (2016) MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1. Development 143:774-9
Desai, Seema S; Tung, Jason C; Zhou, Vivian X et al. (2016) Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology 64:261-75
Huebsch, Nathaniel; Loskill, Peter; Deveshwar, Nikhil et al. (2016) Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses. Sci Rep 6:24726
Mandegar, Mohammad A; Huebsch, Nathaniel; Frolov, Ekaterina B et al. (2016) CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. Cell Stem Cell 18:541-53
Liu, Qiaozhen; Hu, Tianyuan; He, Lingjuan et al. (2015) Genetic targeting of sprouting angiogenesis using Apln-CreER. Nat Commun 6:6020
Tung, Jason C; Barnes, J Matthew; Desai, Shraddha R et al. (2015) Tumor mechanics and metabolic dysfunction. Free Radic Biol Med 79:269-80
Ma, Zhen; Wang, Jason; Loskill, Peter et al. (2015) Self-organizing human cardiac microchambers mediated by geometric confinement. Nat Commun 6:7413

Showing the most recent 10 out of 46 publications